» 2006 » October - Mesothelioma News

Offering hope, help, and support to mesothelioma patients and their families.

News Categories
- 9/11 Asbestos Risks (4)
- Asbestos & Mesothelioma Studies (91)
- Asbestos Abatement (74)
- Asbestos Bankruptcies (1)
- Asbestos in Products (14)
- Asbestos in Schools (24)
- Asbestos Legislation (53)
- Drug Companies (83)
  - ImClone Systems Incorporated (1)
  - Alfacell (27)
  - Bristol-Myers Squibb (1)
  - CuraGen (1)
  - Eli Lilly (19)
  - Fujirebio Diagnostics, Inc. (9)
  - Genentech (1)
  - Innovive Pharmaceuticals (3)
  - NeoPharm, Inc. (1)
  - Raptor Pharmaceuticals Corporation (1)
  - Rosetta Genomics (6)
  - Solbec Pharmaceuticals Ltd (1)
  - TopoTarget (1)
  - Zengen, Inc. (1)
- Full Archive (383)
- Libby, MT (15)
- Novel Treatments & Drugs (99)
  - Avastin (3)
  - Carboplatin (ParaplatinÂ®) (8)
  - Cisplatin (Platinol Â®) (11)
  - Coramsine (1)
  - Gemcitabine (1)
  - histone deacetylase inhibitors (1)
  - melanocortin receptors (MCR) subtypes MC1R and MC3R (1)
  - MESOMARK (8)
  - Mesothelioma Blood Test (12)
  - Onconase (ranpirnase) (23)
  - Pemetrexed (Alimta) (28)
  - Raltitrexed (TomudexÂ®) (1)
- Organizations (200)
  - Asbestos Disease Awareness Organization (ADAO) (69)
  - Cancer Monthly (9)
  - Centers for Disease Control (CDC) (4)
  - Environmental Protection Agency (EPA) (67)
  - Environmental Working Group (EWG) (6)
  - Mesothelioma Applied Research Foundation (MARF) (34)
  - NYU Medical Center (1)
- Polio Vaccine – Simian Virus 40 (SV40) (3)
- Trust Funds (10)
Meso News Archives:
- 2010
- 2009
- 2008
- 2007
- 2006
- 2005
- 2004
- 2003
- 2002
- 2001
- 2000
- 1999
- 1998
You are currently browsing the Mesothelioma News weblog archives for October, 2006.

Archive for October, 2006

Friday, October 27th, 2006 - INNOVIVE Pharmaceuticals Begins Enrollment in Phase I Study of INNO-305 Peptide Immunotherapy in AML, MDS, Mesothelioma and Non-Small Cell Lung Cancer

Tuesday, October 24th, 2006 - Further Analysis of Phase III Data Using CALGB and EORTC Paradigms Reinforces Survival Benefits of ONCONASE® for the Treatment of Patients with Mesothelioma

Friday, October 20th, 2006 - Asbestos Disease Awareness Organization Launches Online Awareness Campaign

Wednesday, October 18th, 2006 - International Conference Focuses on Mesothelioma

Friday, October 6th, 2006 - Chrysotile Asbestos to be Considered for Trade Watch List: Protecting Human Health and Environment From Hazardous Chemicals

Main:

Home | Contact The Mesothelioma Center

Asbestos Diseases:

Asbestos:

About Asbestos | Asbestos in Materials | Products that contain Asbestos

Hope & Help:

Support | Patient Network | Support Groups | Doctors/Specialists

Info & Resources:

Common Questions | News | Web Resources | Site Map

Looking for mesothelioma lawyers? Experienced asbestos attorneys.

Please read our disclaimer. Goldberg, Persky & White, P.C.

Last Updated: March 01, 2010. 09:04:34 pm.

News Categories

Meso News Archives:

Archive for October, 2006